A breastfeeding medicines answer is only as useful as its description of the infant and the exposure. Start with the clinical circumstances, use SPS for UK practice advice, inspect LactMed for the underlying lactation evidence, and treat e-lactancia as an additional specialist resource rather than a colour-coded final verdict.
The resource descriptions here were checked on 6 September 2026. This article is published by iatroX and includes its medicines and learning tools alongside the specialist resources discussed.
Start with two patients, not one medicine
A parent asks whether a prescribed medicine is compatible with breastfeeding. Before searching, establish whether treatment has already started, why it is needed and whether it is working. Clarify the route, duration, other medicines and any relevant maternal illness. Do not infer the actual exposure from a repeat-prescription list alone.
Then ask about the infant. Age, prematurity, current health, feeding pattern and other medicines can change the interpretation. Exclusive breastfeeding is a different exposure context from an older infant taking a small amount of breast milk alongside other feeds. A recommendation written for a healthy term infant should not be silently extended to an unwell premature baby.
The SPS questions-to-ask guide, reviewed on 31 March 2026, explicitly includes maternal and infant factors. It also recognises the benefits of effective maternal treatment and breastfeeding within the risk assessment. The task is not to minimise medicine exposure without considering what the parent needs treatment for.
Read each resource for its particular contribution
SPS breastfeeding resources, updated on 18 February 2026, provide a route into practical UK medicines advice and further specialist support. Read the scope statement before extracting a recommendation. A qualification such as "full term and healthy infants" belongs in the answer, not in a footnote that disappears when the advice is copied.
LactMed describes a referenced, peer-reviewed database covering medicine levels in breast milk and infant blood, reported effects and possible alternatives. As checked on 6 September 2026, it is particularly useful when the question is not just "what is recommended?" but "what observations underpin that recommendation?"
e-lactancia, maintained by APILAM, supplies breastfeeding compatibility information prepared by paediatricians and pharmacists. Its September 2026 site covers more than conventional prescription medicines. Use the individual entry, explanation and references; the overall category cannot convey every detail about infant vulnerability or the quality of available evidence.
None of these descriptions establishes that one resource has independently demonstrated superior accuracy across all medicines. Their practical value depends on the question and on how carefully the relevant entry is read.
A synthetic case that changes halfway through
A fictional patient taking sertraline is breastfeeding a six-week-old infant. Treatment is effective, and the parent is worried after reading that the medicine can enter milk. The infant was born at term, feeds well and has no known medical problems.
The SPS SSRI guidance, checked on 6 September 2026, identifies sertraline and paroxetine as preferred SSRIs in breastfeeding, with recommendations applying to full-term, healthy infants. That is relevant to the case as written. It is not permission to ignore the treatment history, potential infant effects or any subsequent change in health.
A productive next step is to compare the SPS explanation with the LactMed entry, paying attention to the type of evidence and the population described. Then prepare a short explanation of the decision and the observations that would prompt review. Do not supply an unqualified promise that no medicine reaches the infant or that any detectable transfer necessarily causes harm.
Now change one fact: the baby was substantially premature and is still receiving specialist care. The earlier scope statement no longer fits. The correct response is to reassess and seek specialist advice, not to repeat the original compatibility label more confidently. This change in the case tests whether the reader understood the recommendation's conditions.
When two pages appear to disagree
Put the statements side by side and identify what each actually says. One may discuss whether a medicine is a preferred first choice; another may discuss whether breastfeeding can continue when that medicine is already necessary. Those are different decisions.
Check the infant population, route of administration, duration of treatment, available alternatives and publication date. Establish whether a warning comes from a documented adverse effect, a theoretical concern or a lack of evidence. Do not resolve disagreement by choosing whichever website sounds most reassuring.
A useful discrepancy note has four fields: the exact question, the two source statements in your own words, the likely reason they differ, and what remains unresolved. The final field matters most. When the evidence does not settle the decision, the output should be a better specialist question rather than a manufactured consensus.
For complex circumstances, the UK Drugs in Lactation Advisory Service describes its professional advice service and access arrangements. Check those arrangements rather than assuming every service is available to every caller.
Make the patient explanation usable at home
A helpful explanation covers why treatment matters, why the advice fits this infant, what uncertainty remains and what changes should trigger contact. Avoid turning a long technical review into an equally long spoken warning list.
Ask the parent to explain the agreed plan back in their own words. Record any infant monitoring advice from the relevant source or specialist, who will review concerns and whether another clinician needs to be informed. A written resource supports that conversation; it does not establish that the conversation happened.
Match the tool to the next task
Choose SPS for a practice-oriented starting point, LactMed for a closer look at lactation evidence, and e-lactancia for an additional specialist perspective, including relevant non-prescription exposures. Complex or out-of-scope infant circumstances call for individual advice.
For learning after the consultation, iatroX's September 2026 tools offer a different function. Socratic Tutor starts from an attempted question and explores the learner's reasoning. A worthwhile exercise is to explain exactly why the premature-infant variation changes the workflow. Free clinical reference and medicines information can support that learning, but do not replace the specialist lactation resources above.
Frequently asked questions
Is a medicine entering breast milk automatically unsafe?
No, transfer into milk is only part of the assessment. The amount, the infant's circumstances, potential effects and the need for maternal treatment must be considered using medicine-specific evidence.
Can advice for a healthy term infant be used for a premature baby?
Not automatically, because the recommendation's scope may not cover that infant. Reassess the case and obtain appropriate specialist advice where necessary.
Which breastfeeding medicines website is best?
There is no universal winner for every question. SPS, LactMed and e-lactancia have complementary roles, while complex decisions depend on a qualified assessment rather than a website category alone.